Updated International Clinical Recommendations on Scar Management: Part 2—Algorithms for Scar Prevention and Treatment

BACKGROUNDIn 2002, an international advisory panel was convened to assess the scientific literature and develop evidence-based guidance for the prevention and treatment of pathologic scarring. Emerging clinical data, new treatment options, and technical advances warranted a renewed literature search...

Full description

Saved in:
Bibliographic Details
Published inDermatologic surgery Vol. 40; no. 8; pp. 825 - 831
Main Authors Gold, Michael H., McGuire, Michael, Mustoe, Thomas A., Pusic, Andrea, Sachdev, Mukta, Waibel, Jill, Murcia, Crystal
Format Journal Article
LanguageEnglish
Published United States by the American Society for Dermatologic Surgery, Inc 01.08.2014
Subjects
Online AccessGet full text
ISSN1076-0512
1524-4725
1524-4725
DOI10.1111/dsu.0000000000000050

Cover

More Information
Summary:BACKGROUNDIn 2002, an international advisory panel was convened to assess the scientific literature and develop evidence-based guidance for the prevention and treatment of pathologic scarring. Emerging clinical data, new treatment options, and technical advances warranted a renewed literature search and review of the initial advisory panel recommendations. OBJECTIVETo update the management algorithm for pathologic scarring to reflect best practice standards at present. MATERIALS AND METHODSManagement recommendations were derived from clinical evidence amassed during a comprehensive literature search and from the clinical experience and consensus opinion of advisory panel members. RESULTSA combination approach using multiple modalities provides the maximum potential for successful treatment of hypertrophic scars and keloids. The advisory panel advocates a move toward more aggressive initial management of keloids, including earlier application of 5-fluorouracil. A growing body of clinical research supports a place in therapy for newer agents (e.g., bleomycin, onion extract, imiquimod, mitomycin C) and laser therapy (pulsed-dye, fractional) for scar management. CONCLUSIONPrevention and treatment of pathologic scarring requires individualized care built upon the principles of evidence-based medicine and continues to evolve in step with technological and scientific advances.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-4
ObjectType-Conference-2
content type line 23
ObjectType-Instructional Material/Guideline-5
ObjectType-Article-3
ISSN:1076-0512
1524-4725
1524-4725
DOI:10.1111/dsu.0000000000000050